Related Experiment Videos
Measuring stem cell frequency in epidermis: a quantitative in vivo functional assay for long-term repopulating cells
T E Schneider1, C Barland, A M Alex
1Department of Dermatology, University of California, San Francisco, CA 94143, USA.
Summary
Researchers developed a new assay to quantify epidermal stem cells (ESCs). This functional assay reveals ESCs are rare, with 1 in 35,000 epidermal cells capable of long-term tissue repair.
Area of Science:
- Dermatology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Epidermal stem cells (ESCs) are crucial for skin homeostasis, repair, and potential gene therapies.
- A key challenge in ESC research is the absence of a quantitative assay for long-term repopulating cells, hindering purification and characterization.
- Existing hematopoietic stem cell assays provide a model for functional quantitation.
Purpose of the Study:
- To develop and validate a functional assay for quantifying epidermal stem cells (ESCs) in vivo.
- To determine the frequency of long-term repopulating ESCs within the interfollicular epidermis.
- To establish a tool for validating ESC markers and advancing cutaneous stem cell research.
Main Methods:
- Development of a competitive transplantation assay analogous to those used for hematopoietic stem cells.
- Quantification of functional epidermal stem cells capable of long-term epithelial reconstitution.
- Measurement of ESC frequency in interfollicular epidermis and basal epidermal cells.
Main Results:
- A novel functional assay for epidermal stem cells was successfully developed.
- Functional epidermal stem cells reside in the interfollicular epidermis and can reconstitute squamous epithelium.
- The frequency of long-term repopulating epidermal stem cells is approximately 1 in 35,000 total epidermal cells (1 in 10^4 basal cells), significantly lower than previously estimated.
Conclusions:
- The developed assay provides a quantitative measure for epidermal stem cells, crucial for future research.
- The findings reveal a lower frequency of functional epidermal stem cells than previously thought, impacting purification strategies.
- This assay will facilitate the validation of ESC markers, enrichment techniques, and advance gene therapy for skin conditions.